Pavel E Trakhtman Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

5/2011

Recovery of ovarian function and pregnancy in a patient with AML after myeloablative busulphan-based conditioning regimen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pavel E Trakhtman Research Topics

Disease

1	Vascular Remodeling 02/2023
1	Crigler-Najjar Syndrome 02/2023
1	Uremia 02/2023
1	Hematoma 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2011

Drug/Important Bio-Agent (IBA)

1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 02/2023
1	Angiotensin IIBA 02/2023
1	BilirubinIBA 02/2023
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2023
1	Peptides (Polypeptides)IBA 02/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Adenine FDA LinkGeneric 01/2021
1	SolutionsIBA 01/2021
1	citrate phosphate dextrose FDA Link 01/2021
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2021
1	Busulfan (Busulfex)FDA Link 05/2011

Therapy/Procedure

1	Hematopoietic Stem Cell Transplantation 05/2011
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 05/2011